0001209191-19-061544.txt : 20191220
0001209191-19-061544.hdr.sgml : 20191220
20191220161945
ACCESSION NUMBER: 0001209191-19-061544
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191218
FILED AS OF DATE: 20191220
DATE AS OF CHANGE: 20191220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Daly Timothy
CENTRAL INDEX KEY: 0001535896
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38085
FILM NUMBER: 191301775
MAIL ADDRESS:
STREET 1: 20 KINGSBRIDGE ROAD
CITY: PISCATAWAY
STATE: NJ
ZIP: 08854
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ovid Therapeutics Inc.
CENTRAL INDEX KEY: 0001636651
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 465270895
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 212-776-4381
MAIL ADDRESS:
STREET 1: 1460 BROADWAY
STREET 2: SUITE 15044
CITY: NEW YORK
STATE: NY
ZIP: 10036
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-18
0
0001636651
Ovid Therapeutics Inc.
OVID
0001535896
Daly Timothy
C/O OVID THERAPEUTICS INC.
1460 BROADWAY, SUITE 15044
NEW YORK
NY
10036
0
1
0
0
EVP,Finance & Corp. Controller
Stock Option (Right to Buy)
4.42
2019-12-18
4
A
0
125000
0.00
A
2029-12-17
Common Stock
125000
125000
D
25% of the shares subject to the Stock Option will vest and become exercisable on December 18, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
/s/ Danielle Mann for Timothy Daly by POA
2019-12-20